Showing the Way: Oncolytic Adenoviruses as Chaperones of Immunostimulatory Adjuncts

被引:9
作者
Huang, Jing Li [1 ]
LaRocca, Christopher J. [1 ]
Yamamoto, Masato [1 ]
机构
[1] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA
关键词
oncolytic adenovirus; immunotherapy; oncolytic virotherapy; GM-CSF (granulocyte macrophage colony-stimulating factor); interferon-alpha; interferon-gamma; interleukin-12; CD40L; CTLA-4;
D O I
10.3390/biomedicines4030023
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oncolytic adenoviruses (OAds) are increasingly recognized as vectors for immunotherapy in the treatment of various solid tumors. The myriads of advantages of using adenovirus include targeted specificity upon infection and selective replication, which lead to localized viral burst, exponential spread of OAds, and antitumor effect. OAds can also induce a strong immune reaction due to the massive release of tumor antigens upon cytolysis and the presence of viral antigens. This review will highlight recent advances in adenoviral vectors expressing immunostimulatory effectors, such as GM-CSF (granulocyte macrophage colony-stimulating factor), interferon-ff, interleukin-12, and CD40L. We will also discuss the combination of OAds with other immunotherapeutic strategies and describe the current understanding of how adenoviral vectors interact with the immune system to eliminate cancer cells.
引用
收藏
页数:14
相关论文
共 83 条
[1]   Interferon α2b gene delivery using adenoviral vector causes inhibition of tumor growth in xenograft models from a variety of cancers [J].
Ahmed, CMI ;
Johnson, DE ;
Demers, GW ;
Engler, H ;
Howe, JA ;
Wills, KN ;
Wen, SF ;
Shinoda, J ;
Beltran, J ;
Nodelman, M ;
Machemer, T ;
Maneval, DC ;
Nagabhushan, TL ;
Sugarman, BJ .
CANCER GENE THERAPY, 2001, 8 (10) :788-795
[2]   Tumor inflammatory angiogenesis and its chemoprevention [J].
Albini, A ;
Tosetti, F ;
Benelli, R ;
Noonan, DM .
CANCER RESEARCH, 2005, 65 (23) :10637-10641
[3]   Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma [J].
Andtbacka, Robert H. I. ;
Kaufman, Howard L. ;
Collichio, Frances ;
Amatruda, Thomas ;
Senzer, Neil ;
Chesney, Jason ;
Delman, Keith A. ;
Spitler, Lynn E. ;
Puzanov, Igor ;
Agarwala, Sanjiv S. ;
Milhem, Mohammed ;
Cranmer, Lee ;
Curti, Brendan ;
Lewis, Karl ;
Ross, Merrick ;
Guthrie, Troy ;
Linette, Gerald P. ;
Daniels, Gregory A. ;
Harrington, Kevin ;
Middleton, Mark R. ;
Miller, Wilson H., Jr. ;
Zager, Jonathan S. ;
Ye, Yining ;
Yao, Bin ;
Li, Ai ;
Doleman, Susan ;
VanderWalde, Ari ;
Gansert, Jennifer ;
Coffin, Robert S. .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (25) :2780-U98
[4]  
[Anonymous], 2021, LEUKEMIA CHRONIC LYM
[5]   Generation of a novel, cyclooxygenase-2-targeted, interferon-expressing, conditionally replicative adenovirus for pancreatic cancer therapy [J].
Armstrong, Leonard ;
Arrington, Amanda ;
Han, Joohee ;
Gavrikova, Tatyana ;
Brown, Eric ;
Yamamoto, Masato ;
Vickers, Selwyn M. ;
Davydova, Julia .
AMERICAN JOURNAL OF SURGERY, 2012, 204 (05) :741-750
[6]   Delivery of interferon alpha using a novel Cox2-controlled adenovirus for pancreatic cancer therapy [J].
Armstrong, Leonard ;
Davydova, Julia ;
Brown, Eric ;
Han, Joohee ;
Yamamoto, Masato ;
Vickers, Selwyn M. .
SURGERY, 2012, 152 (01) :114-122
[7]  
Atkins MB, 1997, CLIN CANCER RES, V3, P409
[8]   Intravesical Ad-IFNα causes marked regression of human bladder cancer growing orthotopically in nude mice and overcomes resistance to IFN-α protein [J].
Benedict, WF ;
Tao, ZM ;
Kim, CS ;
Zhang, XQ ;
Zhou, JH ;
Adam, L ;
McConkey, DJ ;
Papageorgiou, A ;
Munsell, M ;
Philopena, J ;
Engler, H ;
Demers, W ;
Maneval, DC ;
Dinney, CPN ;
Connor, RJ .
MOLECULAR THERAPY, 2004, 10 (03) :525-532
[9]   Treatment of Pancreatic Cancer With an Oncolytic Adenovirus Expressing Interleukin-12 in Syrian Hamsters [J].
Bortolanza, Sergia ;
Bunuales, Maria ;
Otano, Itziar ;
Gonzalez-Aseguinolaza, Gloria ;
Ortiz-de-Solorzano, Carlos ;
Perez, Daniel ;
Prieto, Jesus ;
Hernandez-Alcoceba, Ruben .
MOLECULAR THERAPY, 2009, 17 (04) :614-622
[10]   Adenovirus delivery provides extended interferon-α exposure and augments treatment of metastatic carcinoma [J].
Brin, E. ;
Atencio, I. ;
Helmich, B. K. ;
Maneval, D. ;
LaFace, D. .
CANCER GENE THERAPY, 2006, 13 (07) :664-675